Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Varian Semiconductor Equipment Associates -- VSEA -- Ignore unavailable to you. Want to Upgrade?

To: robert b furman who wrote (1561)	10/1/2002 10:11:50 AM
From: dantecristo	Respond to of 1929

Why won't Dick Aurelio condemn the terrorists linked to Susan B. Felch's multi-million dollar personal lawsuit paid for by Varian? geocities.com

To: robert b furman who wrote (1561)	10/15/2002 9:08:01 AM
From: Proud_Infidel	Read Replies (1) \| Respond to of 1929

Varian Semiconductor Extends Ion Implantation Market Leadership With Shipment of 100th VIISta Platform System Tuesday October 15, 8:25 am ET GLOUCESTER, Mass.--(BUSINESS WIRE)--Oct. 15, 2002--Varian Semiconductor Equipment Associates, Inc. (Nasdaq:VSEA - News), the leading supplier of ion implantation systems, today announced that it has shipped its 100th single wafer VIISta platform system, achieving a milestone that highlights its position as the leading supplier of ion implant tools. The VIISta 810 HP system will be installed at a major North American microprocessor company. "This milestone order demonstrates the strong demand for our VIISta single wafer ion implant systems," said Ernest Godshalk, president and chief operating officer of Varian Semiconductor. "We believe the productivity and process advantages of the VIISta platform provide cost benefits to our customers, which makes VIISta implanters the best choice for all ion implantation requirements." "The industry's continuing drive for higher performance and lower power microprocessors demands more precise dopant location control during the ion implantation process," said John Aldeborgh, Varian Semiconductor's vice president of sales and marketing. "Only the VIISta platform has the Varian Positioning System (VPS(TM)) which provides the electromechanical and beam optical control to ensure that the ions impact upon the wafer in the correct location and at the desired incident angle. Consequently, the selected dopants are placed in the desired locations of the devices and only those locations. This `atomic level precision' provided by VPS, enables ion implantation to meet the device scaling requirements beyond the 100nm node and has enabled Varian Semiconductor to maintain its leadership position in sales of single wafer ion implant systems." Each implanter in the VIISta platform offers specific advantages in terms of integrated circuit performance. For high current implants, the VIISta 80 presents an opportunity to improve junction abruptness control and increase the drive current and processing speed. For medium current implants, the VIISta 810 HP provides exceptional control of the Vt and halo implants, improving the consistency of operating characteristics and yield across the wafer. For high energy implants, the VIISta 3000 provides accuracy in the placement of dopant species to enhance well-to-well isolation characteristics, reducing the size of the transistors and increasing the number of integrated circuits on the wafer. The VIISta P2LAD ultra low energy ion implanter combines pulsed-plasma doping with the VIISta platform functionality to address the significant technical challenges presented by the requirements of low energy doping for ultra shallow junctions. About Varian Semiconductor Varian Semiconductor Equipment Associates is the leading producer of ion implantation equipment used in the manufacture of semiconductors. The company has headquarters in Gloucester and operates worldwide. Varian Semiconductor maintains a Web site at www.vsea.com. The information contained in the company's Web site is not incorporated by reference into this release, and the Web site address is included in this release as an inactive textual reference only. Note: This release contains forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. For this purpose, the statements concerning the company's expectations regarding the products discussed in this release, market share and technology leadership, technological capabilities and benefits are forward-looking statements and any statements using the terms "believes," "anticipates," "expects," "plans," or similar expressions are forward-looking statements. There are a number of important risks and factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements. These include, among others, volatility in the semiconductor equipment industry; economic conditions in general and as they affect the company's customers; significant fluctuations in the company's quarterly operating results; the impact of rapid technological change; the company's dependence on the development and introduction of new products; the company's concentration on ion implantation systems and related products; concentration in the company's customer base and lengthy sales cycles; the highly competitive market in which the company competes; risks of international sales; foreign currency risks; and general economic conditions; and other factors identified in the company's Annual Report on Form 10-K, and the most recent Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission. The company cannot guarantee any future results, levels of activity, performance or achievement. The company undertakes no obligation to update any of the forward-looking statements after the date of this press release.